Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Consult Clin Psychol. 2018 Oct;86(10):799–809. doi: 10.1037/ccp0000330

Table 3. Results from logistic regression predicting substance free samples at follow-up evaluations.

Follow-up completers only Follow-up non-completers as relapsed
Variable Beta (SE) Wald (df) p value Beta (SE) Wald (df) p value
Baseline variables N = 296 Month 6 N = 360
 Site 4.74 (3) .19 4.07 (3) .25
 Male gender −0.31 (0.27) 1.34 (1) .25 −0.46 (0.24) 3.62 (1) .06
 Age −0.02 (0.01) 2.76 (1) .10 −0.01 (0.01) 1.07 (1) .30
 Income 0.00 (0.00) 3.52 (1) .06 0.00 (0.00) 3.40 (1) .07
 Cocaine negative 0.30 (0.39) 0.63 (1) .43 0.09 (0.37) 0.05 (1) .82
 Opioid negative 0.03 (0.54) 0.00 (1) .96 0.06 (0.51) 0.01 (1) .91
 THC negative 0.78 (0.46) 2.87 (1) .09 0.49 (0.45) 1.19 (1) .27
During treatment variables
 Days attended 0.04 (0.02) 4.01 (1) < .05 0.05 (0.01) 8.92 (1) < .01
 % Negative 0.02 (0.01) 8.64 (1) < .01 0.01 (0.00) 7.98 (1) < .01
Baseline variables N = 292 Month 9 N = 360
 Site 7.06 (3) .07 3.64 (3) .45
 Male gender 0.15 (0.26) 0.00 (1) .95 −0.10 (0.24) 0.17 (1) .68
 Age −0.01 (0.01) 0.75 (1) .39 −0.00 (0.01) 0.06 (1) .81
 Income 0.00 (0.00) 3.57 (1) .06 0.00 (0.00) 2.73 (1) .10
 Cocaine negative 0.38 (0.39) 0.97 (1) .33 0.21 (0.37) 0.32 (1) .56
 Opioid negative −0.06 (0.56) 0.01 (1) .92 0.14 (0.51) 0.08 (1) .78
 THC negative 0.32 (0.45) 0.50 (1) .48 0.16 (0.43) 0.13 (1) .74
During treatment
 Days attended 0.03 (0.02) 3.80 (1) < .05 0.04 (0.02) 8.03 (1) < .01
 % Negative 0.01 (0.01) 4.95 (1) < .05 0.01 (0.01) 4.70 (1) < .03